The effect of positional realignment on dose delivery to the prostate and organs-at-risk for 3DCRT

被引:19
|
作者
Wang, Zhou [1 ]
Rajagopalan, Balu [1 ]
Malhotra, Harish K. [1 ]
Kuettel, Michael R. [1 ]
Podgorsak, Matthew B. [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Radiat Med, Buffalo, NY 14263 USA
关键词
prostate carcinoma; organ motion; ultrasound guidance; 3D conformal radiotherapy; BEAM RADIATION-THERAPY; RADIOTHERAPY; CANCER; MOTION; MARKERS; DISTRIBUTIONS; LOCALIZATION; CARCINOMA;
D O I
10.1016/j.meddos.2006.08.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, we evaluate the impact of daily image-guided patient repositioning on dose delivery to prostate and sensitive organs in the treatment of prostate carcinoma with 3-dimensional conformal radiation therapy (3DCRT). Five patients with substantial ultrasound-documented interfractional prostate motion during their 3DCRT treatment course were selected. Starting with the original treatment plan, 2 additional plans were retrospectively generated for each patient. In one set, organ contours were moved for each fraction, thus simulating positioning with misalignment caused by organ motion if ultrasound guidance were not used. In a second set of plans, the isocenter was shifted, as were the organ contours, simulating realignment based on the ultrasound image. In all cases, the number of planned monitor units was set to those of the original plan. For a given patient, isodose distributions, dose-volume histograms (DVHs), equivalent uniform dose (EUD) for prostate, and generalized equivalent uniform dose (gEUDs) for bladder and rectum were calculated for each fraction and then combined for each shift condition. In all reconstructed plans, the results show no substantial changes in dose coverage of the prostate (< 0.21 % change in EUD) compared to the original plan. However, in some cases with no realignment, a larger volume of the bladder or rectum gets higher dose, with the consequent gEUD for each organ significantly greater compared to the original plan. (C) 2007 American Association of Medical Dosimetrists.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [21] A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for localized, high-risk prostate cancer (RTOG 0521)
    Sandler, Howard M.
    Hu, Chen
    Rosenthal, Seth A.
    Sartor, Oliver
    Gomella, Leonard G.
    Amin, Mahul
    Purdy, James
    Michalski, Jeff M.
    Garzotto, Mark
    Pervez, Nadeem
    Balogh, Alexander G.
    Rodrigues, George
    Souhami, Luis
    Reaume, M. Neil
    Williams, Scott G.
    Hannan, Raquibul
    Horwitz, Eric M.
    Raben, Adam
    Paulus, Rebecca
    Shipley, William U.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (18)
  • [22] A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for localized, high-risk prostate cancer (RTOG 0521).
    Sandler, Howard M.
    Hu, Chen
    Rosenthal, Seth A.
    Sartor, Oliver
    Gomella, Leonard G.
    Amin, Mahul
    Purdy, James
    Michalski, Jeff M.
    Garzotto, Mark
    Pervez, Nadeem
    Balogh, Alexander G.
    Rodrigues, George
    Souhami, Luis
    Reaume, M. Neil
    Williams, Scott G.
    Hannan, Raquibul
    Horwitz, Eric M.
    Raben, Adam
    Paulus, Rebecca
    Shipley, William U.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] Effect of 3DCRT/IMRT/Tomotherapy on left anterior descending artery dose in left breast cancer
    Hegde, Sweekruti
    Bhattacharjee, Somorat
    Pandit, Manjunath S.
    Lohith, G.
    RADIOTHERAPY AND ONCOLOGY, 2024, 197 : S79 - S80
  • [24] Hippocampal dose reduction while treating brain gliomas using 3DCRT
    ElsharkawY, S.
    Abo Gabal, A.
    Hassouna, A.
    Mokhtar, M.
    Hassan, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S462 - S463
  • [25] IMRT or 3DCRT and cardiopulmonary mortality risk in the elderly with Eeophageal cancer
    Lin, S.
    Zhang, N.
    Godby, J.
    Wang, J.
    Marsh, G.
    Liao, Z.
    Komaki, R.
    Ho, L.
    Hofstetter, W.
    Swisher, S.
    Mehran, R.
    Buchholz, T.
    Elting, L.
    Giordano, S.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S58 - S59
  • [26] Variation of Clinically Relevant Dose Indices for 3DCRT of Lung with Respect to Dose Calculation Algorithm
    Adamson, J. D.
    Yoo, S.
    Wu, Q.
    Yin, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S712 - S713
  • [27] Predicting doses to organs-at-risk in prostate cancer intensity modulated radiotherapy
    Mallick, I.
    Saha, S.
    Arunsingh, M.
    Sarkar, A.
    Adhya, D. Guha
    Achari, R.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S854 - S854
  • [28] DOES THE SHAPE OF THE RECTAL SURFACE DOSE DISTRIBUTION PREDICT THE RISK OF LATE RECTAL INCONTINENCE AND BLEEDING, IN PATIENTS TREATED WITH HIGH-DOSE 3DCRT FOR LOCALIZED PROSTATE CANCER?
    Gianolini, S.
    Widesott, L.
    Rancati, T.
    De Martin, E.
    Bianchi, C.
    Monti, A.
    Menegotti, L.
    Pasquino, M.
    Stasi, M.
    Fellin, G.
    Vavassori, V.
    Valdagni, R.
    Fiorino, C.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S320 - S320
  • [29] Understanding the Radiation Dose Variability in Nasopharyngeal Cancer: An Organs-at-Risk Approach
    Bin Sumaida, Abdulrahman
    Shanbhag, Nandan M.
    Balaraj, Khalid S.
    Puratchipithan, Rajmane
    Hasnain, Syed Mansoor
    El-Koha, Omran
    Hussain, Amjad
    Binz, Theresa
    Rajendran, Vivek T.
    Nair, Rajaneesh Kumar R.
    Jaafar, Noor H.
    Saleh, Mohammad
    Al Qawasmeh, Khaled
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [30] Predicting dose-volume histograms for organs-at-risk in IMRT planning
    Appenzoller, Lindsey M.
    Michalski, Jeff M.
    Thorstad, Wade L.
    Mutic, Sasa
    Moore, Kevin L.
    MEDICAL PHYSICS, 2012, 39 (12) : 7446 - 7461